SAKAR2025-04-012025-06-30SAKAR2025-06-30SAKAR2025-06-30in-bse-shp:IndividualsOrHinduUndividedFamilyMemberSAKAR2025-06-30in-bse-shp:IndianMemberSAKAR2025-06-30in-bse-shp:ShareholdingOfPromoterAndPromoterGroupMemberSAKAR2025-06-30in-bse-shp:AlternativeInvestmentFundsMemberSAKAR2025-06-30in-bse-shp:InstitutionsDomesticMemberSAKAR2025-06-30in-bse-shp:InstitutionsForeignPortfolioInvestorCategoryOneMemberSAKAR2025-06-30in-bse-shp:InstitutionsForeignPortfolioInvestorCategoryTwoMemberSAKAR2025-06-30in-bse-shp:InstitutionsForeignMemberSAKAR2025-06-30in-bse-shp:KeyManagerialPersonnelMemberSAKAR2025-06-30in-bse-shp:ResidentIndividualShareholdersHoldingNominalShareCapitalUpToRsTwoLakhMemberSAKAR2025-06-30in-bse-shp:ResidentIndividualShareholdersHoldingNominalShareCapitalInExcessOfRsTwoLakhMemberSAKAR2025-06-30in-bse-shp:NonResidentIndiansMemberSAKAR2025-06-30in-bse-shp:BodiesCorporateMemberSAKAR2025-06-30in-bse-shp:OtherNonInstitutionsMemberSAKAR2025-06-30in-bse-shp:NonInstitutionsMemberSAKAR2025-06-30in-bse-shp:PublicShareholdingMemberSAKAR2025-06-30in-bse-shp:ShareholdingPatternMemberSAKAR2025-04-012025-06-30IndividualsOrHUF_Context15SAKAR2025-06-30IndividualsOrHUF_Context15SAKAR2025-04-012025-06-30IndividualsOrHUF_Context16SAKAR2025-06-30IndividualsOrHUF_Context16SAKAR2025-04-012025-06-30IndividualsOrHUF_Context17SAKAR2025-06-30IndividualsOrHUF_Context17SAKAR2025-04-012025-06-30IndividualsOrHUF_Context18SAKAR2025-06-30IndividualsOrHUF_Context18SAKAR2025-04-012025-06-30AlternativeInvestmentFunds_Context15SAKAR2025-06-30AlternativeInvestmentFunds_Context15SAKAR2025-04-012025-06-30DetailsOfSharesHeldByBodiesCorporate_Context15SAKAR2025-06-30DetailsOfSharesHeldByBodiesCorporate_Context15SAKAR2025-04-012025-06-30DetailsOfSharesHeldByInstitutionsForeignPortfolioInvestorTwo_Context15SAKAR2025-06-30DetailsOfSharesHeldByInstitutionsForeignPortfolioInvestorTwo_Context15SAKAR2025-04-012025-06-30DetailsOfSharesHeldByInstitutionsForeignPortfolioInvestorTwo_Context16SAKAR2025-06-30DetailsOfSharesHeldByInstitutionsForeignPortfolioInvestorTwo_Context16SAKAR2025-04-012025-06-30OtherNonInstitutions_Context15SAKAR2025-06-30OtherNonInstitutions_Context15SAKAR2025-04-012025-06-30OtherNonInstitutions_Context16SAKAR2025-06-30OtherNonInstitutions_Context16SAKAR2025-03-31SAKAR2024-12-31SAKAR2024-09-30SAKAR2024-06-30xbrli:purexbrli:shares000000SAKARNOTLISTEDINE732S01012Sakar Healthcare Limited******************2025-06-30******falsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsetruetruetruefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalsefalse4117610431176104352.86117610431176104352.861176104352.862000001.70117610434117610431176104352.86117610431176104352.861176104352.862000001.70117610434117610431176104352.86117610431176104352.861176104352.862000001.701176104332503121250312111.252503121250312111.25250312111.2500.00250312100032503121250312111.252503121250312111.25250312111.2500.002503121000164133641330.2964133641330.29641330.2900.006413300032919051291905113.122919051291905113.12291905113.1200.00291905100042983184298318413.412983184298318413.41298318413.4100.0029831840001220.00220.0020.0000.00200076952627470262747011.812627470262747011.81262747011.8100.002627470000209011879011874.059011879011874.059011874.0510000011.1090118700013095288952880.4395288952880.43952880.4300.009528800055115035811503585.17115035811503585.1711503585.1720000017.3911503580002032282572282571.032282572282571.032282571.0300.0022825700081045002562500256222.485002562500256222.48500256222.483000006.0050025620008111104888671048886747.14104888671048886747.141048886747.143000002.861048886700081152224991022249910100.002224991022249910100.00222499101005000002.25222499100001. The Company, on 17th June, 2025, has allotted 3,00,000 Equity Shares to Non-Promoters pursuant to conversion of Warrants in accordance with the applicable provision of the Companies Act, 2013, SEBI (ICDR) Regulations, 2018 & NSE In principle approval granted vide Ref. no. Ref: NSE/LIST/38623 dated 20th December, 2023 under Regulation 28(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has made Listing application to NSE for their approval in respect of above allotted 3,00,000 Equity Shares and upon receipt of Listing approval of NSE it will get aforesaid Equity Shares credited in the demat account of respective allottee(s) by getting executed necessary Corporate Action with CDSL & NSDL in accordance with the provisions of applicable SEBI Rules and Regulations. The effect of allotment of above 3,00,000 shares with lock-in conditions has been given in the present Shareholding pattern. However, the same may not be reflected in SDD SHP. 2. The shareholding held by Foregin Portfolio Investors and shown bifurcating the Category of FPI in the Shareholding pattern is based on the Benpos/ Shareholders data provided by the RTA of the Company.******Sanjay S Shah******100085431000854344.98100085431000854344.981000854344.98100000110008543******1Shah Aarsh******140750014075006.33140750014075006.3314075006.331000007.11407500******1Ritaben Shah******2450002450001.12450002450001.12450001.100245000******1Shah Ayushi******1000001000000.451000001000000.451000000.4500100000******1Tata Capital Healthcare Fund II******2309910230991010.382309910230991010.38230991010.380023099100001Hi-Tech Chemicals Limited******6296996296992.836296996296992.836296992.8320000031.766296990001Hbm Healthcare Investments (Cayman) Ltd******150000015000006.74150000015000006.7415000006.740015000000001Cobra India (Mauritius) Limited******141888614188866.38141888614188866.3814188866.380014188860001LLPCategory1082457824570.3782457824570.37824570.370082457000HUFCategory1931458001458000.661458001458000.661458000.660014580000010013.6710013.9110013.9810013.6610013.83